Roxadustat for CKD-related Anemia in Non-dialysis Patients

INTRODUCTION: Roxadustat is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor that stimulates erythropoiesis and improves iron metabolism. We assessed the efficacy and tolerability of roxadustat in patients with chronic kidney disease (CKD)-related anemia not on dialysis. METHODS: ANDES...

Descripción completa

Detalles Bibliográficos
Autores principales: Coyne, Daniel W., Roger, Simon D., Shin, Sug Kyun, Kim, Sung Gyun, Cadena, Andres A., Moustafa, Moustafa A., Chan, Tak Mao, Besarab, Anatole, Chou, Willis, Bradley, Charles, Eyassu, Meraf, Leong, Robert, Lee, Tyson T., Saikali, Khalil G., Szczech, Lynda, Yu, Kin-Hung P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938196/
https://www.ncbi.nlm.nih.gov/pubmed/33732977
http://dx.doi.org/10.1016/j.ekir.2020.11.034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938196/
https://www.ncbi.nlm.nih.gov/pubmed/33732977
http://dx.doi.org/10.1016/j.ekir.2020.11.034

Ejemplares similares